PALATIN TECHNOLOGIES, INC. Accounts Payable
PALATIN TECHNOLOGIES, INC. (PTN) had Accounts Payable of $1.69 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-05-13
- 2026-03-31: Accounts Payable, Current $1.69M.
- 2025-12-31: Accounts Payable, Current $5.45M.
- 2025-09-30: Accounts Payable, Current $7.41M.
- 2025-06-30: Accounts Payable, Current $7.00M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-03-31 | $1.69M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.45M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $7.41M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $7.00M 10-Q · filed 2026-05-13 | |
| 2025-03-31 | $7.77M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $6.72M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $3.95M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.10M 10-K · filed 2025-09-23 | |
| 2024-03-31 | $3.44M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.59M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $2.27M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $4.30M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $2.79M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $820.30K 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $3.77M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $3.16M 10-K · filed 2023-09-28 | |
| 2022-03-31 | $2.40M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $160.18K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $762.82K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $640.65K 10-K · filed 2022-09-22 | |
| 2021-03-31 | $864.01K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.17M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $971.31K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $715.67K 10-K · filed 2021-09-28 | |
| 2020-03-31 | $1.61M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $135.17K 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $57.82K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $504.79K 10-K · filed 2020-09-25 | |
| 2019-03-31 | $474.77K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $619.90K 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $1.17M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $2.22M 10-K · filed 2019-09-12 | |
| 2018-03-31 | $793.64K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $703.77K 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $2.03M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $1.55M 10-K · filed 2018-09-13 | |
| 2017-03-31 | $1.24M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.71M 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $1.16M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $713.89K 10-K · filed 2017-09-25 | |
| 2016-03-31 | $1.78M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $2.38M 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $3.44M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $1.11M 10-K · filed 2016-09-19 | |
| 2015-03-31 | $2.33M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $1.91M 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $561.36K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $261.28K 10-K · filed 2015-09-18 | $1.51M 10-K · filed 2014-09-12 |
| 2014-03-31 | $431.77K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $290.99K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $990.90K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $1.70M 10-K · filed 2014-09-12 | $338.73K 10-K · filed 2013-09-27 |
| 2013-03-31 | $733.44K 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $484.81K 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $321.62K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $294.89K 10-K · filed 2013-09-27 | |
| 2012-03-31 | $557.90K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $580.57K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $336.21K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $496.91K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |